These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 48829)

  • 41. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.
    Mukhtar ED; Smith BR; Pyle GA; Hall R; Vice P
    Lancet; 1975 Mar; 1(7909):713-5. PubMed ID: 47482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)].
    Zao WS; Wang SZ
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):119-25. PubMed ID: 6895561
    [No Abstract]   [Full Text] [Related]  

  • 44. [Role of autoimmune processes in thyroid diseases].
    Aleksandrova GF; Vnotchenko SL
    Probl Endokrinol (Mosk); 1980; 26(3):78-85. PubMed ID: 6773042
    [No Abstract]   [Full Text] [Related]  

  • 45. Recurrent thyrotoxicosis after subtotal thyroidectomy.
    Hedley AJ; Ross IP; Beck JS; Donald D; Albert-Recht F; Michie W; Crooks J
    Br Med J; 1971 Oct; 4(5782):258-61. PubMed ID: 5171384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease].
    Leövey A
    Orv Hetil; 1978 Aug; 119(33):2019-21. PubMed ID: 209384
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
    Szabó J; Fórizs E; Szabó T; Leövey A
    Acta Med Hung; 1986; 43(3):275-81. PubMed ID: 3035480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 51. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 52. Thyroid-stimulating activity in the serum of immunized rabbits. II. Nature of the thyroid-stimulating material.
    Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1968 Oct; 28(10):1496-502. PubMed ID: 5681643
    [No Abstract]   [Full Text] [Related]  

  • 53. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 56. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1969 Oct; 43(4):1427-32. PubMed ID: 5395131
    [No Abstract]   [Full Text] [Related]  

  • 59. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
    Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
    [No Abstract]   [Full Text] [Related]  

  • 60. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
    Yoshikawa N; Mori S; Tokoro T; Ikehara S; Kumazawa H; Yamashita T; Nishikawa M; Inada M
    Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.